Viewing Study NCT00412828


Ignite Creation Date: 2025-12-26 @ 10:33 AM
Ignite Modification Date: 2025-12-26 @ 10:33 AM
Study NCT ID: NCT00412828
Status: COMPLETED
Last Update Posted: 2015-02-19
First Post: 2006-12-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
Sponsor: CuraGen Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module